BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200428
DTEND;VALUE=DATE:20200501
DTSTAMP:20260515T074935
CREATED:20200218T083428Z
LAST-MODIFIED:20200218T083428Z
UID:24226-1588032000-1588291199@www.pharmajournalist.com
SUMMARY:Manufacturing Assets & Facility Management in Pharma
DESCRIPTION:Pharma\, biotechs and CMOs have witnessed a major transformation with the continued adoption of digital manufacturing and emerging technologies using AI and big data. We have seen pioneers\, including the likes of Sanofi and Merck\, to maximize asset value\, increase plant reliability and ensure production continuity through digitization. \nThe inaugural Manufacturing Assets & Facility Management (MAFM) in Pharma Summit has been specifically designed to help you manage cost pressures and boost productivity through digitization where you will advance various aspects of asset and facility management programs such as clarity of asset inventory\, asset lifecycle\, facility footprint and sustainability. \n \nWhy is this Event for You? Join this cutting-edge discussion to: \n\nGet up to speed with the digital transformation to streamline operations\nFind new approaches to strategic asset management to improve inventory visibility\nUse data to enhance asset utilization and track the full lifecycle of assets\nEmploy energy and sustainability initiatives to reduce utilities spend\nManage MRO processes to improve productivity and reduce costs\n\nImmerse yourself in this industry-led meeting with the likes of Merck\, CSL Behring and Seattle Genetics. This event is dedicated to exploring strategies in the manufacturing environment where you will join 60+ senior experts from functions of Manufacturing Engineering\, Manufacturing Operations\, Facility Management\, Asset Management\, Procurement and Maintenance & Reliability across pharma\, biotech and CMOs. \nRegister with your team today and don’t miss out on this unique meeting to engage with peers and re-define best practice for tomorrow’s operations.
URL:https://www.pharmajournalist.com/event/manufacturing-assets-facility-management-in-pharma/
LOCATION:Wyndham Boston Beacon Hill 5 Blossom Street Boston\, MA\, MA 02114\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200429
DTEND;VALUE=DATE:20200430
DTSTAMP:20260515T074935
CREATED:20200407T145113Z
LAST-MODIFIED:20200407T145318Z
UID:24936-1588118400-1588204799@www.pharmajournalist.com
SUMMARY:Recombinant Chromogenic Assay as Alternate Methods for the Bacterial Endotoxins Test (BET)
DESCRIPTION:Recombinant Chromogenic Assay as Alternate Methods for the Bacterial Endotoxins Test (BET)\nConference: 29 April 2020 – 10am EDT (3pm BST – UK time)\nLocation: WEBINAR\nWebsite: https://www.smi-online.co.uk/pharmaceuticals/webinar/recombinant-chromogenic-assays \nHOSTED BY: Associate of Cape Cod\nLED BY: Veronika Wills\, Manager\, Technical Services\, Associates of Cape Cod \n \nRecently\, there has been a lot of interest associated with the potential use of synthetic (non-animal based) reagents for bacterial endotoxin testing. This webinar will provide an in-depth overview of the global perspective on the use of such reagents\, including their regulatory status. \nThis free to join webinar is sponsored by Associate of Cape Cod\, the one hour webinar will focus on executing a recombinant kinetic chromogenic assay\, testing samples and detailed data interpretation with the primary focus on comparability of the data with conventional amoebocyte lysate- based assays. \nBENEFITS FOR JOINING THE WEBINAR: \nThis interactive webinar will provide the following benefits: \n\nAn overview of global status of recombinant reagents for BET\nA session on kinetic chromogenic testing\nData interpretation\nTroubleshooting kinetic chromogenic assays\nEquivalency of the recombinant reagents to LAL reagents\n\nWHO SHOULD JOIN? \n\nSenior Microbiologists\nLead Scientists\nLaboratory Managers\nQA Specialists\nDrug Substance External Manufacturers\nQC Scientists\nHeads of Quality\nBusiness Development Managers\nPharmaceutical Microbiology Consultants\nHigher Pharmacopoeia Scientists\nAnalytical Standards Specialists\n\nFor full details and to register your free place\, please visit: https://www.smi-online.co.uk/pharmaceuticals/webinar/recombinant-chromogenic-assays
URL:https://www.pharmajournalist.com/event/recombinant-chromogenic-assay-as-alternate-methods-for-the-bacterial-endotoxins-test-bet/
LOCATION:WEBINAR
ORGANIZER;CN="SMi Group":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
END:VCALENDAR